Review



mouse monoclonal anti-basic fgf (bfgf  (Biomol GmbH)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Biomol GmbH mouse monoclonal anti-basic fgf (bfgf
    Mouse Monoclonal Anti Basic Fgf (Bfgf, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti-basic+fgf+(bfgf/mouse+monoclonal+anti+basic+fgf++bfgf/pmc06757897-118-58-64
    Average 90 stars, based on 1 article reviews
    mouse monoclonal anti-basic fgf (bfgf - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Expressing:

    Article Title: Transplantation of Olfactory Mucosa Minimizes Axonal Branching and Promotes the Recovery of Vibrissae Motor Performance after Facial Nerve Repair in Rats
    Article Snippet: To monitor the expression of trophic factors at the lesion site at the end of the experiments, longitudinal cryosections (20 μm) through the facial nerve 2 months after FFA-only, FFA + OM, or FFA + BMM were incubated with (1) mouse monoclonal anti-NGF (1:50; Roche; cat. no. 1087754), (2) mouse monoclonal anti-BDNF (1:1000; R&D Systems; MAB 248), (3) mouse monoclonal anti-basic FGF (bFGF) (1:50; UBI/Biomol; cat. no. 05-117), (4) goat polyclonal anti-rat CNTF (1:100; R&D Systems; AB557-NA), (5) mouse monoclonal anti-IGF-I (1:50; UBI/Biomol; cat. no. 05-172), (6) mouse monoclonal anti-GDNF (1:500; R&D Systems; MAB 212), (7) rabbit polyclonal anti-S-100 protein (1:1000; Dako Diagnostika, Hamburg, Germany).

    Article Title: Transplantation of Olfactory Mucosa Minimizes Axonal Branching and Promotes the Recovery of Vibrissae Motor Performance after Facial Nerve Repair in Rats
    Article Snippet: To monitor the expression of trophic factors at the lesion site at the end of the experiments, longitudinal cryosections (20 m) through the facial nerve 2 months after FFA-only, FFA OM, or FFA BMM were incubated with (1) mouse monoclonal anti-NGF (1:50; Roche; cat. no. 1087754), (2) mouse monoclonal anti-BDNF (1:1000; R&D Systems; MAB 248), (3) mouse monoclonal anti-basic FGF (bFGF) (1:50; UBI/Biomol; cat. no. 05-117), (4) goat polyclonal anti-rat CNTF (1:100; R&D Systems; AB557-NA), (5) mouse monoclo- nal anti-IGF-I (1:50; UBI/Biomol; cat. no. 05-172), (6) mouse monoclonal anti-GDNF (1:500; R&D Systems; MAB 212), (7) rabbit polyclonal anti-S-100 protein (1:1000; Dako Diagnostika, Hamburg, Germany).

    Incubation:

    Article Title: Transplantation of Olfactory Mucosa Minimizes Axonal Branching and Promotes the Recovery of Vibrissae Motor Performance after Facial Nerve Repair in Rats
    Article Snippet: To monitor the expression of trophic factors at the lesion site at the end of the experiments, longitudinal cryosections (20 μm) through the facial nerve 2 months after FFA-only, FFA + OM, or FFA + BMM were incubated with (1) mouse monoclonal anti-NGF (1:50; Roche; cat. no. 1087754), (2) mouse monoclonal anti-BDNF (1:1000; R&D Systems; MAB 248), (3) mouse monoclonal anti-basic FGF (bFGF) (1:50; UBI/Biomol; cat. no. 05-117), (4) goat polyclonal anti-rat CNTF (1:100; R&D Systems; AB557-NA), (5) mouse monoclonal anti-IGF-I (1:50; UBI/Biomol; cat. no. 05-172), (6) mouse monoclonal anti-GDNF (1:500; R&D Systems; MAB 212), (7) rabbit polyclonal anti-S-100 protein (1:1000; Dako Diagnostika, Hamburg, Germany).

    Article Title: Transplantation of Olfactory Mucosa Minimizes Axonal Branching and Promotes the Recovery of Vibrissae Motor Performance after Facial Nerve Repair in Rats
    Article Snippet: To monitor the expression of trophic factors at the lesion site at the end of the experiments, longitudinal cryosections (20 m) through the facial nerve 2 months after FFA-only, FFA OM, or FFA BMM were incubated with (1) mouse monoclonal anti-NGF (1:50; Roche; cat. no. 1087754), (2) mouse monoclonal anti-BDNF (1:1000; R&D Systems; MAB 248), (3) mouse monoclonal anti-basic FGF (bFGF) (1:50; UBI/Biomol; cat. no. 05-117), (4) goat polyclonal anti-rat CNTF (1:100; R&D Systems; AB557-NA), (5) mouse monoclo- nal anti-IGF-I (1:50; UBI/Biomol; cat. no. 05-172), (6) mouse monoclonal anti-GDNF (1:500; R&D Systems; MAB 212), (7) rabbit polyclonal anti-S-100 protein (1:1000; Dako Diagnostika, Hamburg, Germany).



    Similar Products

    mouse monoclonal anti-basic fgf (bfgf) igg1 neutralizing rat bfgf (clone bfm-1)  (Upstate Biotechnology Inc)
    90
    Upstate Biotechnology Inc mouse monoclonal anti-basic fgf (bfgf) igg1 neutralizing rat bfgf (clone bfm-1)
    Mouse Monoclonal Anti Basic Fgf (Bfgf) Igg1 Neutralizing Rat Bfgf (Clone Bfm 1), supplied by Upstate Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti-basic+fgf+(bfgf/anti+myc/10__1523_slash_jneurosci__5186___05__2006-42-0-14
    Average 90 stars, based on 1 article reviews
    mouse monoclonal anti-basic fgf (bfgf) igg1 neutralizing rat bfgf (clone bfm-1) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    mouse monoclonal anti-basic fgf (bfgf) igg1 neutralizing rat bfgf bfm-1  (Upstate Biotechnology Inc)
    90
    Upstate Biotechnology Inc mouse monoclonal anti-basic fgf (bfgf) igg1 neutralizing rat bfgf bfm-1
    <t>Anti-bFGF</t> antibodies and lipid extractions with organic solvents do not prevent neuroprotection by CMAPOE− supplemented with human apoE2. Four DIV rat neuronal cultures were treated for 2 d with MK801 (2.5 μm) with or without Aβ (40 μg/ml) or CMAPOE- supplemented with apoE2 (80 nm). A, B, CDM and CMAPOE− were extracted three times with diethyl ether (A) or with n-hexane (B) before supplementation of CMAPOE- with human apoE2 and incorporation into 4 DIV cultures (see Materials and Methods). The MAP2 O.D. is expressed as the percentage of the mean value determined in untreated neuronal cultures defined as 100%. C, Anti-bFGF <t>IgG</t> (50 μg/ml) was added to 4 DIV cultures as indicated, and neuronal survival was quantified by counts of the number of MAP2-positive cells. Data are means ± SD from five determinations in sister wells from one (C) or two (A, B) independent experiments.
    Mouse Monoclonal Anti Basic Fgf (Bfgf) Igg1 Neutralizing Rat Bfgf Bfm 1, supplied by Upstate Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti-basic+fgf+(bfgf/anti+myc/pmc06674113-150-0-14
    Average 90 stars, based on 1 article reviews
    mouse monoclonal anti-basic fgf (bfgf) igg1 neutralizing rat bfgf bfm-1 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    mouse monoclonal anti-basic fgf (bfgf  (Biomol GmbH)
    90
    Biomol GmbH mouse monoclonal anti-basic fgf (bfgf
    <t>Anti-bFGF</t> antibodies and lipid extractions with organic solvents do not prevent neuroprotection by CMAPOE− supplemented with human apoE2. Four DIV rat neuronal cultures were treated for 2 d with MK801 (2.5 μm) with or without Aβ (40 μg/ml) or CMAPOE- supplemented with apoE2 (80 nm). A, B, CDM and CMAPOE− were extracted three times with diethyl ether (A) or with n-hexane (B) before supplementation of CMAPOE- with human apoE2 and incorporation into 4 DIV cultures (see Materials and Methods). The MAP2 O.D. is expressed as the percentage of the mean value determined in untreated neuronal cultures defined as 100%. C, Anti-bFGF <t>IgG</t> (50 μg/ml) was added to 4 DIV cultures as indicated, and neuronal survival was quantified by counts of the number of MAP2-positive cells. Data are means ± SD from five determinations in sister wells from one (C) or two (A, B) independent experiments.
    Mouse Monoclonal Anti Basic Fgf (Bfgf, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti-basic+fgf+(bfgf/mouse+monoclonal+anti+basic+fgf++bfgf/pmc06757897-118-58-64
    Average 90 stars, based on 1 article reviews
    mouse monoclonal anti-basic fgf (bfgf - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Anti-bFGF antibodies and lipid extractions with organic solvents do not prevent neuroprotection by CMAPOE− supplemented with human apoE2. Four DIV rat neuronal cultures were treated for 2 d with MK801 (2.5 μm) with or without Aβ (40 μg/ml) or CMAPOE- supplemented with apoE2 (80 nm). A, B, CDM and CMAPOE− were extracted three times with diethyl ether (A) or with n-hexane (B) before supplementation of CMAPOE- with human apoE2 and incorporation into 4 DIV cultures (see Materials and Methods). The MAP2 O.D. is expressed as the percentage of the mean value determined in untreated neuronal cultures defined as 100%. C, Anti-bFGF IgG (50 μg/ml) was added to 4 DIV cultures as indicated, and neuronal survival was quantified by counts of the number of MAP2-positive cells. Data are means ± SD from five determinations in sister wells from one (C) or two (A, B) independent experiments.

    Journal: The Journal of Neuroscience

    Article Title: System X c − and Apolipoprotein E Expressed by Microglia Have Opposite Effects on the Neurotoxicity of Amyloid-β Peptide 1–40

    doi: 10.1523/JNEUROSCI.5186-05.2006

    Figure Lengend Snippet: Anti-bFGF antibodies and lipid extractions with organic solvents do not prevent neuroprotection by CMAPOE− supplemented with human apoE2. Four DIV rat neuronal cultures were treated for 2 d with MK801 (2.5 μm) with or without Aβ (40 μg/ml) or CMAPOE- supplemented with apoE2 (80 nm). A, B, CDM and CMAPOE− were extracted three times with diethyl ether (A) or with n-hexane (B) before supplementation of CMAPOE- with human apoE2 and incorporation into 4 DIV cultures (see Materials and Methods). The MAP2 O.D. is expressed as the percentage of the mean value determined in untreated neuronal cultures defined as 100%. C, Anti-bFGF IgG (50 μg/ml) was added to 4 DIV cultures as indicated, and neuronal survival was quantified by counts of the number of MAP2-positive cells. Data are means ± SD from five determinations in sister wells from one (C) or two (A, B) independent experiments.

    Article Snippet: Mouse monoclonal anti-basic FGF (bFGF) IgG1 neutralizing rat bFGF (clone bFM-1) was obtained from Upstate Biotechnology (Euromedex, Mundolsheim, France).

    Techniques: